Perrigo (PRGO) EBITDA Margin (2012 - 2026)
Perrigo (PRGO) posted quarterly EBITDA Margin of 38.41% for Q1 2026, down 4291.0% year-over-year from 0.92% in Q1 2025, and up 66.88% quarter-over-quarter from 116.0% in Q4 2025.
Perrigo (PRGO) EBITDA Margin (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has reported EBITDA Margin for 15 consecutive years, with 38.41% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBITDA Margin fell 4291.0% year-over-year to 38.41%; the TTM figure through Mar 2026 stood at 36.89% (down 4185.0% YoY), while the FY2025 annual figure was 26.39%, down 2897.0% from the prior year.
- EBITDA Margin improved to 38.41% in Q1 2026 per PRGO's latest filing, from 116.0% in the prior quarter.
- Across five years, EBITDA Margin topped out at 10.03% in Q4 2024 and bottomed at 116.0% in Q4 2025.
- Historically, EBITDA Margin has averaged 6.39% across 5 years, with a median of 3.01% in 2022.
- Annual changes were most pronounced in 2022 — EBITDA Margin jumped 1222 bps — and 2025, when it tumbled 12603 bps.
- Perrigo's EBITDA Margin stood at 2.68% in 2022, then tumbled by 150 bps to 1.35% in 2023, then surged by 844 bps to 10.03% in 2024, then tumbled by 1256 bps to 116.0% in 2025, then soared by 67 bps to 38.41% in 2026.
- Business Quant data shows PRGO's EBITDA Margin at 38.41% in Q1 2026, 116.0% in Q4 2025, and 6.96% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Perrigo | 1.93 Bn | 1.53 Bn | 313.90 Mn | 2.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 2.30% |
| Mar 28, 2026 | -38.41% |
| Dec 31, 2025 | -116.00% |
| Sep 27, 2025 | 6.96% |
| Jun 28, 2025 | 4.30% |
| Mar 29, 2025 | 4.49% |
| Dec 31, 2024 | 10.03% |
| Sep 28, 2024 | 7.39% |
| Jun 29, 2024 | -2.49% |
| Mar 30, 2024 | -5.10% |
| Dec 31, 2023 | -1.35% |
| Sep 30, 2023 | 5.53% |
| Jul 1, 2023 | 4.76% |
| Apr 1, 2023 | 4.10% |
| Dec 31, 2022 | 2.68% |
| Oct 1, 2022 | 3.01% |
| Jul 2, 2022 | -0.62% |
| Apr 2, 2022 | 2.02% |
| Dec 31, 2021 | 4.23% |
| Oct 2, 2021 | 42.04% |